News search

E.g., 04/03/2026
E.g., 04/03/2026
From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
Research
26 Feb 2026

The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines

Dos proyectos del CNIC seleccionados en la convocatoria Investigación en Salud 2025 de la Fundación ”la Caixa”
About the CNIC
20 Nov 2025

In this latest round, the la Caixa Foundation Health Research Call has selected 34 new cutting-edge biomedical research projects

Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
Research
16 Apr 2024

The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity

Imagen
About the CNIC
29 Jun 2021

 Over one million European cancer patients suffer from side effects to chemotherapy

Research
3 Apr 2018

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián

Research
10 Jan 2017

The findings, published in Nature Medicine, suggest a major potential for NOS2 inhibitors in the treatment of thoracic aortic aneurysa

Research
21 Dec 2016

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián


Ingenuity PET-MRI de Philips de humanos (Equipo híbrido clínico de Tomografía por Emisión de Positrones-Resonancia Magnética) 5
About the CNIC
8 Sep 2016

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián

Research
23 Oct 2015

El centro vasco de investigación cooperativa en biomateriales Biomagune y el Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) han firmado un convenio de colaboración.